EULAR 2025 highlights… EULAR 2025 Highlights – Metabolic and Crystal arthropathies 18 Jul 2025 Genakumab reduces the risk of acute gout flares during initiation of urate-lowering therapy: A phase 2, randomized, open-label, multi-center, active-controlled clinical trial Abstract format and assignment number: Oral presentation OP0299…
ACR Congress Do Not Miss… ACR Convergence 2024: Do Not Miss – Metabolic and crystal arthropathies 5 Nov 20246 Nov 2024 Juan C Sarmiento-Monroy, MD, MScJuan C. is a Rheumatologist and clinical research fellow at the Hospital Clinic of Barcelona. His main research interests include the validation of biomarkers in RA-ILD…
EULAR 2024 Highlights… EULAR 2024 Highlights – Metabolic and Crystal arthropathies 21 Jul 202421 Jul 2024 Author: Juan C Sarmiento-Monroy Brikman et al. (OP0003) developed a machine learning-based prediction model for identifying hyperuricemic participants at risk of developing gout. The model demonstrated relatively good performance and…
ACR Congress Do Not Miss… ACR Convergence 2023: Do Not Miss – Metabolic and crystal arthropathies 6 Nov 2023 Juan C Sarmiento-MonroyJuan C. is a Rheumatologist and clinical research fellow at the Hospital Clinic of Barcelona. His main research interests include the validation of biomarkers in RA-ILD and the…
Metabolic and Crystal Arthropathies Metabolic & Crystal Arthropathies 29 May 202329 May 2023 Diego Benavent Diego is a consultant rheumatologist at Hospital Universitario La Paz in Madrid, where he is doing his PhD on axial spondyloarthritis. He also collaborates as medical expert in…
Metabolic and Crystal Arthropathies [ACR22] Metabolic and Crystal Arthropathies 29 Nov 20226 Dec 2022 Author: Diego Benavent Botson et al (0001) assessed the efficacy and safety of pegloticase (PEGylated uricase) with methotrexate (MTX) vs placebo (PBO) as co-therapy, in the MIRROR RCT trial. Efficacy…